期刊文献+

药源性溶血性贫血 被引量:5

原文传递
导出
摘要 药物为双刃剑,一面有治疗疾病之效使患者康复,也可因使用不当或个体易感发生不良反应,增加患者病痛甚至危及生命。众所周知,药物不良反应谱多,人体所有器官系统均可出现不良反应,确切发生率不清,约占所有药物不良反应的10%。表现不一,如贫血、白细胞减少、血小板减少、出血或血栓栓塞等,而药源性溶血性贫血仅占药源性血液学反应中10%。本文只讨论药源性溶血性贫血,其溶血机制复杂。有免疫性、氧化性、微血管病性和其他,有些药物不止一种溶血机制。引起药源性溶血性贫血的药物过多,不一一列出,仅代表性举出数种。
作者 林凤茹
出处 《国际输血及血液学杂志》 CAS 2009年第6期490-493,共4页 International Journal of Blood Transfusion and Hematology
  • 相关文献

参考文献9

  • 1林辉,郑淑华,陈一农.药源性溶血性贫血文献报道123例综合分析[J].中国临床药学杂志,2003,12(1):38-39. 被引量:7
  • 2Hoffman R,Benz EJJr,Shattil SJ,et al.血液病学基本原理与实践(上册).第3版.北京:科学出版社,2001:pp555-571,624-626,636-637.
  • 3张之南,沈悌,主编.血液学诊断与疗效标准.第3版,北京:科学出版社.2007,pp59-68,78-87.
  • 4Johnson ST, Fueger JT, Gottschall JL. One center's experience : the serology and drugs associated with drug-induced immune hemolytic anemia-a new paradigm. Transfusion, 2007, 47 (4) : 697- 702.
  • 5Arndt PA, Garratty G. The changing spectrum of drug induced immune hemolytic anemia. Sematol Hematol, 2005, 42 (3) : 137- 144.
  • 6李卉,杨丽,欧阳锡林,刘景汉,王全立.β内酰胺类抗生素导致药源性溶血的初步研究[J].中国实验血液学杂志,2006,14(3):597-600. 被引量:3
  • 7Zakarija A,Bennett C. Drug induced thrombotic microangiopathy. Semin Thromb Hemost, 2005, 31(6):681-690.
  • 8Khuu T, Shayani S, Palmer J, et al. Thrombotic microangiopathy with tacrolimus / sirolimus-based GVHD prophylaxis regimen in patients wndergoing hematopoietic stem cell transplant from a matched unrelated donor. Blood, 2008, 112(11) :296.
  • 9姜红.葛根素注射液致急性溶血性贫血反应35例文献分析[J].天津药学,2008,20(4):38-39. 被引量:5

二级参考文献10

  • 1崔岚,祝德秋,陶达人.葛根素药理作用研究进展[J].中国药师,2004,7(12):924-927. 被引量:41
  • 2Dhaliwal G,Comett PA,Tierney LM,et al.Hemolytic anemia.Am Fam Physician,2004; 69:2599-2606
  • 3Garratty G,Amdt PA.Positive direct antiglobulin tests and haemolyric anaemia following therapy with beta-lactamase inhibitor containing drugs may be associated with non-immunologic adsorption of protein onto red cells.Br J Haematol,1998; 100:777-783
  • 4Broadberry RE,Farren TW,Bevin SV,et al.Tazobactam-induced haemolytic anaemia,possibly caused by non-immunological adsorption of IgG onto patient's red cells.Transfus Med,2004; 14:53 -57
  • 5Williams ME,Thomas D,Harman CP,et al.Positive direct antiglobulin tests due to clavulanic acid.Antimicrob Agents Chemother,1985; 27:125-127
  • 6Garratty G,Leger R.Red cell membrane proteins (CD55 and CD58) are modified following treatment of RBCs with cephalosporins.Blood,1995; 86:68-70
  • 7Jamin D,Demers J,Shulman I,et al.An explanation for nonimmunologic adsorption of protein onto red blood cells:Schiff's base reactions.Blood,1986; 67:993-996
  • 8Arndt P,Garratty G.Can non-specific protein coating of RBCs lead to increased RBC destruction? Drug-treated RBCs with positive antiglobulin tests due to non-specific protein uptake give positive monocyte monolayer assays.Transfusion,2000; 40:29-31
  • 9Richard L G, Foerster J, Lukens J, et al. Wintrobe's Clinical Hematology. 10th ed. Baltimore Philadelphia: Williams & Wilkins, 1998. 1251
  • 10李梅,杨柳,黄伟强,杨正鸿.不同厂家葛根素注射液溶血试验比较[J].广西医科大学学报,2001,18(4):520-520. 被引量:19

共引文献12

同被引文献41

  • 1李津婴.遗传性红细胞酶病[M] //溶血性疾病.李津婴,万树栋.上海:复旦大学出版社,2008:175-180.
  • 2万树栋.溶血性疾病总论.李津婴,万树栋,主编.溶血性疾病.复旦大学出版社.2008.4l一71.
  • 3Bemstein DI,EI Sahly HM, Keitel WA, et al. Safety and immunoge- nicity of a candidate parvovirus B19 vaccine. Vaccine,2011,29(43 ) : 7357-7363.
  • 4Lombardi F, Quitadamo AL, Notarangelo leD, et al. Varicella zoster vi- rus-induced hemolytic crisis in an infant with severe vitamin B12 defi- ciency. J Pediatr Hematol Oncol,2010,32(4) :317-318.
  • 5Oliveira MC, Femandes RA, Rodrigues CL, et al. Clinical course of 63 children with hereditaly spherocytosis: a retrospective study. Rev BrasHematol Hemoter,2012,34( 1 ) :9-13.
  • 6A1-Habbouhi HH, Mahdi N, Ahu-Hijleh TM ,et al. The retation of vas- cular endothelial gq'owth factor (VEGF) gene polymoq)hisms on VEGF levels and the risk of vasooeelusive crisis in sickle cell disease. Eur J Haematol, 2012,89 ( 5 ) : 403-409.
  • 7Zanotto MI, Calvo K, Schvartzman G, et al. Hemolytic anemia due to hemoglobin Evans in an Argentinean family. Arch Argent Pediatr, 2010,108(6) :e130-133.
  • 8Rider NL, Strauss KA, Brown K, e| al. E:throcyte pyruvate kinase de- ficiency in an old-order Amish cohort: longitudinal risk and disease management. Am J Hematol,2011,86 ( 10 ) : 827-834.
  • 9Billot S,Mouton A, Lhote F, et al. Cerebral infarction, a complication of paroxysmal nocturnal haemoglobinuria. Rev Neurol,2007,163 ( 1 ) : 138-141.
  • 10Borthakur G, O'Brien S, Wierda WG, et al. Immune anaemias in pa- tients with chronic lymphocytic leukaemia treated with fludarabine, cy- clophosphamide and rituximab-incidence and predictors. Br J Haema- tol,2007,136 ( 6 ) : 800-805.

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部